A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients.
about
Current management and perspectives for HCV recurrence after liver transplantationGlucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patientsAntibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipientsAntibody induction versus corticosteroid induction for liver transplant recipientsCorticosteroid-free immunosuppression in liver transplantation: an evidence-based review.Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?A prospective, randomized trial of complete avoidance of steroids in liver transplantation with follow-up of over 7 yearsManagement of HCV transplant patients with triple therapy.Hepatitis C virus and liver transplantation: where do we stand?Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal.Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.Anti-interleukin-2 receptor antibodies for the prevention of rejection in liver transplant recipients: a systematic review and meta-analysis.Steroid minimization immunosuppression protocol using basiliximab in adult living donor liver transplantation for hepatitis C virus-related cirrhosis.REFINE: a randomized trial comparing cyclosporine A and tacrolimus on fibrosis after liver transplantation for hepatitis C.Randomized, multicenter trial comparing tacrolimus plus mycophenolate mofetil to tacrolimus plus steroids in hepatitis C virus-positive recipients of living donor liver transplantation.Liver transplant complications in hepatitis C infected recipients: recurrence versus rejection.The impact of immunosuppressant therapy on the recurrence of hepatitis C post-liver transplantation.
P2860
Q22299427-ADEEF3EB-B84A-4FC7-8E7B-8AC27C46409AQ24187112-703671CC-03E2-44A9-83C2-8422038E3D47Q24194087-96BC850A-46A2-47A4-9D94-D3600E79299BQ24194518-928D6B92-9173-486C-92F5-35C8B32F5930Q34067842-623A03FC-3634-4667-80C6-A49AE4C1BAE3Q34093760-3C2D6475-2C33-46BA-9E8F-BC52D0A7BDF3Q35790393-91FA4BE2-8C76-46A0-AD63-F0F91AB6A8D4Q36718780-732FF8CD-C655-4E47-8113-FEC0CC1EF481Q38174249-667EC0A1-27B6-4017-A238-EDE9B52D872FQ38551818-256562E9-51D4-49FC-9120-2965F5562A6EQ38682284-EF9E3446-A70A-4DD9-959E-7AE772F812D7Q38737314-861E027D-8B23-4751-8648-8F03CB4F4D12Q38998606-C048FEC1-9BA6-47D2-AD73-8577989DDB8AQ41573767-EC6C7CF6-82CE-4313-839F-52D81E2F8C23Q42241628-503391DE-587D-4CD0-9A35-ECBD4427FAC2Q42992322-67530CC3-39CE-4886-A3CD-BF577FDF5B8FQ44686044-4A32E17F-BAA0-490E-B03B-D14A3E084DC8Q55692477-B070AE0A-2BCE-4689-81C7-32B075C79EC5
P2860
A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A Randomized Multicenter Study ...... ve Liver Allograft Recipients.
@ast
A Randomized Multicenter Study ...... ve Liver Allograft Recipients.
@en
type
label
A Randomized Multicenter Study ...... ve Liver Allograft Recipients.
@ast
A Randomized Multicenter Study ...... ve Liver Allograft Recipients.
@en
prefLabel
A Randomized Multicenter Study ...... ve Liver Allograft Recipients.
@ast
A Randomized Multicenter Study ...... ve Liver Allograft Recipients.
@en
P2093
P2860
P356
P1476
A Randomized Multicenter Study ...... ve Liver Allograft Recipients.
@en
P2093
Didier Samuel
Giorgio Enrico Gerunda
Jean Gugenheim
Pavel Trunečka
Styrbjörn Friman
Ulf Neumann
P2860
P304
P356
10.1155/2012/894215
P577
2012-05-28T00:00:00Z